Opus Genetics, Inc. (IRD)
About Opus Genetics, Inc.
Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes seven adeno-associated virus (AAV)-based programs, led by OPGx-LCA5 for LCA5-related mutations and OPGx-BEST1 for BEST1-related retinal degeneration, with additional candidates targeting RHO, CNGB1, RDH12, NMNAT1, and MERTK. The company operates in one operating segment, which is the business of developing products related to vision performance and health.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $14.2M
- Net income
- -$49.6M
- Total assets
- $50.2M
- Market cap
- $254.3M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $254.3M
- Shares outstanding
- 73.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 6, 2020
Opus Genetics, Inc. (IRD) Stock Price
- Reported a net loss of $49.6M in FY2025.
- Trading 43% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Opus Genetics, Inc..
Write a review
News about Opus Genetics, Inc.
News & sentiment via Polygon.io
Opus Genetics, Inc.: frequently asked questions
Is Opus Genetics, Inc. an American company?
Opus Genetics, Inc. is a US-based company headquartered in Durham, North Carolina, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Opus Genetics, Inc. headquartered?
Opus Genetics, Inc. is headquartered in Durham, North Carolina, United States.
Is Opus Genetics, Inc. publicly traded?
Yes — Opus Genetics, Inc. is a publicly traded company. Its stock trades under the ticker symbol IRD on the NASDAQ.
What does Opus Genetics, Inc. do?
Opus Genetics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
